SKP2 and pulmonary fibrosis: Because fibrotic changes began one week after BLM-injection and were more evident and extensive after two weeks, we evaluated the effects of Skp2-deficiency at a relatively early stage of pulmonary fibrosis progression using Skp2-deficient mice two weeks after BLM-injection.